MET and seminoma: In the present study, we investigated the role of ERK in the HGF-independent and HGF-dependent (c-MET activated) malignant behavior of NT2D1 non-seminoma cells, studying the effects of pharmacological ERK inhibition on the already described biological responses to HGF (proliferation, migration, chemotaxis) [4].